SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the pricing of (i) $45.0 million aggregate principal amount of senior secured convertible notes due ...
Q3 2024 revenue was $6.1 million, which comprises $6.6 million in core product and software sales which is offset by $0.5 million because of a write-down of aged receivables tied to discontinued ...
SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated ...
Hosted on MSN
Bionano raises 2025 OGM installation target to 25 as consumables and software revenue climbs 16%
CEO Robert Erik Holmlin described the second quarter of 2025 as “solid,” emphasizing the positive effects of the strategic shift made in September 2024, which prioritized supporting routine users of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results